MARI PARKER: Open Payments
NPI 1093066284 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 39 payments from 18 companies in 2025. Trend: 2023 $1,077 · 2024 $1,700 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 6 | $192 |
| Sumitomo Pharma America, Inc. | 4 | $105 |
| TOLMAR, INC. | 4 | $100 |
| Astellas Pharma US Inc | 4 | $80 |
| PFIZER INC. | 3 | $75 |
| Janssen Biotech, Inc. | 2 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Boston Scientific Corporation | 2 | $54 |
| UROGEN PHARMA, INC. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
Products named: XYOSTED, Xtandi, GEMTESA, ERLEADA, Nubeqa, SpaceOAR VUE System - 10mL, JATENZO, JELMYTO.
Industry payments across VA — which companies pay providers there.
